NCT03081715View on ClinicalTrials.gov

PD-1 Knockout Engineered T Cells for Advanced Esophageal Cancer

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 14, 2017

Primary Completion Date

January 23, 2018

Study Completion Date

February 28, 2018

Conditions
Esophageal Cancer
Interventions
OTHER

PD-1 Knockout T Cells

Programmed cell death 1(PD-1) gene will be knocked out by CRISPR Cas9

Trial Locations (1)

310002

Hangzhou Cancer Hospital, Hangzhou

All Listed Sponsors
collaborator

Anhui Kedgene Biotechnology Co.,Ltd

UNKNOWN

lead

Hangzhou Cancer Hospital

OTHER

NCT03081715 - PD-1 Knockout Engineered T Cells for Advanced Esophageal Cancer | Biotech Hunter | Biotech Hunter